Canadian Implantable Defibrillator Study (CIDS)
Stuart J. Connolly(Population Health Research Institute), Bernard O’Brien(McMaster University), Denis‐Claude Roy(Hôpital Maisonneuve-Rosemont), Robert S. Sheldon(University of Calgary), Paul Dorian(St. Michael's Hospital), Robin S. Roberts(Impact), Michael Gent(University of Aberdeen), Martin S. Green(McMaster University), L. Brent Mitchell(McMaster University), George J. Klein(Western University)
Cited by 1,601
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Subclinical Atrial Fibrillation and the Risk of Stroke
|New England Journal of Medicine|2012|2.1k
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure
|New England Journal of Medicine|2010|1.8k
Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
|New England Journal of Medicine|2008|1.6k
Prophylactic Use of an Implantable Cardioverter–Defibrillator after Acute Myocardial Infarction
|New England Journal of Medicine|2004|1.5k